Latest News & Features
Big Pharma
The unitary patent and Unified Patent Court will have wide-ranging implications for life sciences companies. In the first of what will be a regular column on the topics by law firm Taylor Wessing, Paul England explores current developments on issues such as costs and judges. 19 February 2015
Big Pharma
A US court has ruled that an AstraZeneca patent covering asthma inhaler Pulmicort Respules is invalid, allowing generic drug makers to enter the market with their own versions. 17 February 2015
Americas
The Canadian government has given a scathing assessment of Eli Lilly’s patenting practices in its formal response to the pharmaceutical company’s CAD $500 million lawsuit against it. 16 February 2015
Genetics
The High Court of Australia is set to consider the Myriad Genetics case concerning whether isolated genetic material is patentable subject matter. 16 February 2015
Americas
Law firm Kaye Scholer has added a team of three life sciences and technology lawyers to its intellectual property group. 13 February 2015
Americas
Novartis has sued drug company BPI Labs for alleged patent infringement after it requested permission to market a generic version of Novartis’s bone cancer drug Zometa. 12 February 2015
Big Pharma
A medical aid non-profit organisation has opposed a European patent held by pharmaceutical company Gilead that covers its anti-hepatitis C drug Sovaldi. 11 February 2015
Americas
Bayer’s animal health division has filed for a declaratory judgment that SHP Chemical has infringed three patents covering a range of products that control fleas affecting cats and dogs. 9 February 2015
Americas
Law firm Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has bolstered its life sciences practice again, adding a group of five lawyers to its Washington, DC office. 6 February 2015
Americas
US pharmaceutical company Pfizer has agreed to buy drug company Hospira, in an acquisition that will include its biosimilar portfolio. 6 February 2015